Tofacitinib for the treatment of ulcerative colitis: Up to 5.4 years of safety data from global clinical trials

被引：5
|
作者：
Sandborn, W. J. [1 ]
Panes, J. [2 ]
Panaccione, R. [3 ]
D'Haens, G. R. [4 ]
Sands, B. E. [5 ]
Su, C. [6 ]
Moscariello, M. [6 ]
Jones, T. V. [6 ]
Pedersen, R. D. [6 ]
Friedman, G. S. [6 ]
Lawendy, N. [6 ]
Chan, G. [6 ]
机构：
[1] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA
[2] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
[3] Univ Calgary, Calgary, AB, Canada
[4] Acad Med Ctr, Dept Gastroenterol, Amsterdam, Netherlands
[5] Icahn Sch Med Mt Sinai, Dr Henry D Janowitz Div Gastroenterol, New York, NY 10029 USA
[6] Pfizer Inc, Collegeville, PA USA
来源：
JOURNAL OF CROHNS & COLITIS | 2019年 / 13卷
关键词：
D O I：
10.1093/ecco-jcc/jjy222.590
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P466
引用
收藏
页码：S344 / S344
页数：1
相关论文
共 50 条
  • [1] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 5.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS
    Sandborn, William J.
    Panes, Julian
    Panaccione, Remo
    D'Haens, Geert R.
    Sands, Bruce E.
    Su, Chinyu
    Moscariello, Michele
    Jones, Thomas V.
    Pedersen, Ronald D.
    Friedman, Gary S.
    Lawendy, Nervin
    Chan, Gary
    GASTROENTEROLOGY, 2019, 156 (06) : S1097 - S1097
  • [2] Tofacitinib for the treatment of ulcerative colitis: up to 4.4 years of safety data from global clinical trials
    Sandborn, W. J.
    Panes, J.
    D'Haens, G. R.
    Sands, B. E.
    Su, C.
    Moscariello, M.
    Jones, T. V.
    Pedersen, R. D.
    Friedman, G. S.
    Lawendy, N.
    Chan, G.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S45 - S46
  • [3] Tofacitinib for the Treatment of Ulcerative Colitis: Up to 7.8 Years of Safety Data from Global Clinical Trials
    Sandborn, William
    D'Haens, Geert
    Sands, Bruce E.
    Panaccione, Remo
    Ng, Siew C.
    Lawendy, Nervin
    Kulisek, Nicole
    Guo, Xiang
    Mundayat, Rajiv
    Su, Chinyu
    Panes, Julian
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S360 - S360
  • [4] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 4.4 YEARS OF SAFETY DATA FROM GLOBAL CLINICAL TRIALS
    Sandborn, William J.
    Panes, Julian
    D'Haens, Geert R.
    Sands, Bruce E.
    Su, Chinyu
    Moscariello, Michele
    Jones, Thomas V.
    Pedersen, Ronald D.
    Friedman, Gary S.
    Lawendy, Nervin
    Chan, Gary
    GASTROENTEROLOGY, 2018, 154 (06) : S178 - S178
  • [5] Tofacitinib for the Treatment of Ulcerative Colitis: Up to 6.8 Years of Safety Data From Global Clinical Trials
    Sandborn, William J.
    Panes, Julian
    D'Haens, Geert R.
    Sands, Bruce E.
    Panaccione, Remo
    Ng, Siew C.
    Jones, Thomas V.
    Lawendy, Nervin
    Kulisek, Nicole
    Mundayat, Rajiv
    Su, Chinyu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S353 - S354
  • [6] Safety of Tofacitinib for Treatment of Ulcerative Colitis, Based on 4.4 Years of Data From Global Clinical Trials
    Sandborn, William J.
    Panes, Julian
    D'Haens, Geert R.
    Sands, Bruce E.
    Su, Chinyu
    Moscariello, Michele
    Jones, Thomas
    Pedersen, Ron
    Friedman, Gary S.
    Lawendy, Nervin
    Chan, Gary
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2019, 17 (08) : 1541 - 1550
  • [7] Tofacitinib for the Treatment of Ulcerative Colitis: Up to 9.2 Years of Safety Data From the Global Clinical Program
    Panes, Julian
    D'Haens, Geert R.
    Sands, Bruce E.
    Ng, Siew C.
    Lawendy, Nervin
    Kulisek, Nicole
    Guo, Xiang
    Wu, Joseph
    Vranic, Ivana
    Panaccione, Remo
    Vermeire, Severine
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S910 - S910
  • [8] Etrasimod for the treatment of ulcerative colitis: up to 2.5 years of pooled safety data from global clinical trials
    Vermeire, S.
    Peyrin-Biroulet, L.
    Panes, J.
    Regueiro, M.
    Kotze, P. G.
    Charabaty, A.
    Goetsch, M.
    Shan, K.
    Wu, J.
    McDonnell, A.
    Woolcott, J.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 619 - 619
  • [9] ETRASIMOD FOR THE TREATMENT OF ULCERATIVE COLITIS: UP TO 2.5 YEARS OF POOLED SAFETY DATA FROM GLOBAL CLINICAL TRIALS
    Vermeire, Severine
    Peyrin-Biroulet, Laurent
    Panes, Julian
    Regueiro, Miguel D.
    Kotze, Paulo G.
    Charabaty, Aline
    Goetsch, Martina
    Shan, Kevin
    Wu, Joseph
    McDonnell, Aoibhinn
    Woolcott, John
    Danese, Silvio
    GASTROENTEROLOGY, 2023, 164 (06) : S207 - S207
  • [10] TOFACITINIB FOR THE TREATMENT OF ULCERATIVE COLITIS: AN INTEGRATED SUMMARY OF SAFETY DATA FROM THE GLOBAL OCTAVE AND RIVETING CLINICAL TRIALS
    Sandborn, William J.
    D'Haens, Geert R.
    Sands, Bruce E.
    Panaccione, Remo
    Ng, Siew C.
    Lawendy, Nervin
    Kulisek, Nicole
    Guo, Xiang
    Mundayat, Rajiv
    Su, Chinyu
    Panes, Julian
    GASTROENTEROLOGY, 2022, 162 (07) : S228 - S229
12345